SecBot SecBot
SC 13G ·Filed Nov 13, 2026

AGEN

AGENUS INC
NEUTRAL
Impact 3/10
Horizonweeks Processed3d 8h ago SEC0001580642-26-007713
Passive investor 5%+ stake
Actionable Insight • Neutral

Monitor for any future amendments that increase the stake above 5.4% or a conversion to Schedule 13D if the fund's intent changes. The passive nature and moderate size suggest limited near-term trading impact.

DirectionNeutral
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Eventide Asset Management disclosed a 5.4% passive stake in Agenus Inc via Schedule 13G, representing 2,446,789 shares held through its Healthcare & Life Sciences Fund as of September 30, 2026. The filing certifies no intent to influence control, and the stake size is modest relative to the company's $327M market cap.

Key Financial Metrics

Stake
5.4%
Investor
Eventide Asset Management, LLC
Investor Type
mutual fund

Key Facts

  • Eventide Asset Management filed Schedule 13G disclosing beneficial ownership of 2,446,789 shares of Agenus common stock
  • Stake represents 5.4% of outstanding shares as of September 30, 2026
  • Shares are held via Eventide Healthcare & Life Sciences Fund, a registered investment company
  • Filing certifies passive intent under Rule 13d-1(b) with no purpose of changing or influencing control
  • Joint filers include Finny Kuruvilla and Robin C. John, each disclaiming beneficial ownership

Financial Impact

2,446,789 shares, 5.4% of outstanding, valued at approximately $17.7M based on $327M market cap

ownership concentration

Risk Factors

  • Passive 13G status could change if Eventide later engages with management or seeks board representation
  • Fund could reduce position without further public disclosure until below 5%

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0001580642-26-007713
Document: 0001580642-26-007713-index.html0001580642-26-007713
Document: 0001580642-26-007713.txt0001580642-26-007713

Track record

12 reports on AGEN

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +138.65% at T+60 after the May 11, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $6.35 Now $6.29 −0.94% settles Feb 16
  2. Nov 13, 20263d ago SC 13G Neutral 3/10 Viewing Entry $6.97 Now $6.29 −9.76% settles Feb 12
  3. Nov 5, 202611d ago 8-K Neutral 4/10 Entry $6.44 Now $6.29 −2.33% settles Feb 3
  4. Aug 12, 202613w ago 8-K Neutral 2/10 Entry $7.00 to $6.90 Now $6.29 −10.14% ▼ −1.43% +3.81% vs SPY
  5. Aug 12, 202613w ago Institutional Cluster Mixed 4/10 Entry $6.90 to $6.97 Now $6.29 −8.84% ▲ +1.01% +5.89% vs SPY
  6. Aug 7, 202614w ago S-3 Bearish 7/10 Entry $7.00 to $6.76 Now $6.29 +10.14% ▲ +3.43% +1.53% vs SPY
  7. Aug 6, 202614w ago 8-K Neutral 5/10 Entry $7.49 to $6.84 Now $6.29 −16.02% ▼ −8.68% −7.01% vs SPY
  8. Jul 17, 202617w ago S-3 Bearish 5/10 Entry $4.97 to $6.95 Now $6.29 −26.56% ▼ −39.84% −35.00% vs SPY
  9. Jul 13, 202618w ago 8-K Bearish 6/10 Entry $6.12 to $7.49 Now $6.29 −2.78% ▼ −22.39% −18.39% vs SPY
  10. May 13, 202626w ago DEFA14A Neutral 4/10 Entry $3.47 to $6.96 Now $6.29 +81.27% ▲ +100.58% +96.14% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens in 8h

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026